1.50432

LiChrosorb^® RP-8 (5 µm) HPLC Columns

L x I.D. 125 mm x 4 mm, Hibar^® RT HPLC Column

• 别名: TM=["LiChrosorb"] C8 HPLC column
• 分類程式碼代碼: 41115709
• NACRES: SB.52

属性

• 产品名称: LiChrosorb^® RP-8 (5 µm) Hibar^® RT 125-4, suitable for HPLC
• 材料: stainless steel column
• 品質等級: 100
• agency: suitable for USP L7
• 產品線: LiChrosorb^®
• 特點: endcapped: no
• 參數: 400 bar pressure; 60 °C max. temp.
• 技術: HPLC: suitable; mass spectrometry (MS): suitable (Low)
• 柱長度 × 內徑: 12.5 cm × 4 mm
• 基質: fully porous particle
• 基質活性組: C8 bonding phase
• 粒徑: 5 μm
• 孔徑: 100 Å pore size
• 工作pH值範圍: 2-7.5
• 分離技術: reversed phase; supercritical fluid (SFC)
• 儲存溫度: no temp limit

说明

一般說明

HPLC色谱柱

LiChrosorb^® RP-8 是一个可靠的形状不规则的硅胶载体，具有反相特性。它非常适合分离中性、酸性和弱碱性化合物。该吸附剂装在Hibar 125-4 HPLC色谱柱中。在安装LiChroCART 4-4保护柱时，必须使用保护柱支架1.51487。

應用

• Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.: This study by Egger et al. focuses on the HPLC determination of various forms of amphotericin B in plasma, utilizing LiChrosorb^® RP-8 as the stationary phase. This method ensures accurate monitoring of these antifungal agents in clinical settings (Egger et al., 2001).


• Determination of peptide hydrophobicity parameters by reversed-phase high-performance liquid chromatography.: This research by Rothemund et al. used LiChrosorb^® RP-8 to determine the hydrophobicity of various peptides, providing valuable insights for peptide characterization in biochemical research (Rothemund et al., 1994).


• HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.: Beijnen et al. employed LiChrosorb^® RP-8 in an HPLC method to quantify doxorubicin and its metabolites in plasma, offering a robust tool for therapeutic drug monitoring in AIDS patients (Beijnen et al., 1991).

分析報告

压力： ≤ 50 bar
理论塔板数（N/m）（甲苯）： ≥ 55000
对称性（甲苯）：0.8-1.4
容量系数（甲苯）：0.5 - 1.5

法律資訊

Hibar is a registered trademark of Merck KGaA, Darmstadt, Germany

LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany